Criteria for comparisons and recommendations for a next generation of Chimeric Antigen Receptor (CAR) T cells as HIV-1 treatment
Combination antiretroviral therapy (cART) for Human Immunodeficiency Virus Type 1 (HIV-1) treatment is limited in its ability to target HIV reservoirs that cause a viral rebound in patients. Chimeric antigen receptor (CAR) T cell therapy is a developing treatment to address this issue. Several gener...
Saved in:
主要作者: | |
---|---|
格式: | text |
語言: | English |
出版: |
Animo Repository
2022
|
主題: | |
在線閱讀: | https://animorepository.dlsu.edu.ph/etdb_bio/19 https://animorepository.dlsu.edu.ph/cgi/viewcontent.cgi?article=1021&context=etdb_bio |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
成為第一個發表評論!